“Use of this dragon cartoon logo is not only distracting, it is juvenile and impertinent,” Judge Kent wrote. “The Court is not a cartoon.” Judge Kent gave the woman, who was identified ...

“Sanofi has long advocated for changes to the 340B Program, which has been plagued by insufficient HRSA oversight and well-documented misuse,” the company said in a Dec. 17 statement sent to ...

The Health Resources and Services Administration (HRSA) announced last week a $52 million investment in 54 health centers to improve access to primary care for those preparing to leave incarceration.

A sign with the company logo sits outside of the headquarters of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Eli Lilly is suing the federal government over how hospitals ...

The HRSA had argued that the J&J proposal violates federal law governing the 340B program ...

"HRSA expects J&J to cease implementation of its rebate proposal immediately and to inform HRSA no later than Sept. 30, 2024, in order to provide adequate notice to covered entities." ...

HRSA further informed the AHA that it has told J&J that it would take appropriate action as warranted. A spokesperson for J&J said its "limited scope rebate model is fully consistent with the 340B ...

Health Resources and Services Administration HRSA court decision on 340B patient definitions and its potential implications for. Skip to main content June 28, 2025 ...

HRSA’s more restrictive definition of a 340B-eligible patient—which required that a covered entity must initiate the services resulting in the relevant prescription in order to claim them as ...

This reverses a 2020 HRSA policy that aimed to streamline 340B certifications during the height of the COVID-19 pandemic. Related: HRSA silence on 340B drug discount status worries hospitals.